RecruitingNot ApplicableNCT07306221

Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstruction


Sponsor

Peking University Third Hospital

Enrollment

45 participants

Start Date

Nov 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the improvement effect of visual-guided balance training on the knee joint function and gait performance of patients after ACLR, and to clarify the advantages of this training program compared to conventional rehabilitation training; at the same time, by including healthy individuals as the control group, it quantifies the differences in knee joint function and gait performance between patients after ACLR and healthy individuals, to verify whether visual-guided balance training can more effectively narrow the functional gap between patients after ACLR and healthy individuals, and promote the recovery of patients' knee joint function and gait closer to the healthy level. Ultimately, it provides scientific theoretical basis and practical guidance for the optimization of the rehabilitation plan after ACLR, and helps patients achieve comprehensive and high-quality recovery.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Inclusion Criteria10

  • Age between 18 and 45 years old;
  • Body Mass Index (BMI) ranging from 18.5 kg/m² to less than 35 kg/m²;
  • First unilateral ACL rupture and reconstruction surgery performed at this hospital;
  • Autologous hamstring tendon transplantation;
  • No or only minor injury to the meniscus, posterior cruciate ligament, medial collateral ligament or lateral collateral ligament;
  • Voluntary participation in this study and signing of informed consent form.
  • Age 18-45 years old;
  • Body Mass Index (BMI) ≥ 18.5 kg/m2 and < 35 kg/m2;
  • No surgical history, injury history, or chronic joint diseases of the lower extremities;
  • No visual, cognitive impairments or neurological diseases;

Exclusion Criteria6

  • Patients who underwent ACL reconstruction more than one year after the injury;
  • Patients with severe injuries to the posterior cruciate ligament, medial collateral ligament or lateral collateral ligament (more than grade I; grade II is partial tear, thickening and tortuosity of the ligament, partial fiber interruption, and swelling of the surrounding soft tissues; grade III is complete rupture). ; Combined with severe meniscus tear;
  • Has a history of previous knee surgery, such as meniscus repair, ligament reconstruction, joint replacement, joint cleaning, etc.;
  • Has other knee joint diseases, such as: knee osteoarthritis, knee joint tumor, rheumatoid arthritis, tuberculosis, knee joint infection or inflammatory diseases, fracture, dislocation or other bone injuries, etc.;
  • Severe heart, lung, brain diseases or liver and kidney dysfunction, and visual and cognitive impairments.
  • \. Poor compliance of the subject; 2. The subject withdraws the informed consent form; 3.The subject requests to terminate the study or is unable to complete all the trials for some reason; 4. The investigator believes that the subject's continued participation in the trial may cause significant adverse effects on their physical condition; 5. The ethics review committee decides to terminate the trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTraditional group

Based on the traditional standardized rehabilitation program, additional universal balance training content has been added. Starting from the 5th week after the surgery and continuing until the 14th week, three times a week for a total of 10 weeks, the training duration was one and a half hours each time.

OTHERIntervention Group

Based on the conventional standardized rehabilitation program, add the content of visual-guided balance training.Starting from the 5th week after the surgery and continuing until the 14th week, three times a week for a total of 10 weeks, the training duration was one and a half hours each time.


Locations(1)

Peking University Third Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07306221


Related Trials